HBGHX
Price
$14.33
Change
-$0.30 (-2.05%)
Updated
Dec 18 closing price
VGHCX
Price
$201.50
Change
-$3.95 (-1.92%)
Updated
Dec 18 closing price
Ad is loading...

HBGHX vs VGHCX

Header iconHBGHX vs VGHCX Comparison
Open Charts HBGHX vs VGHCXBanner chart's image
Hartford Healthcare HLS IB
Price$14.33
Change-$0.30 (-2.05%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$201.50
Change-$3.95 (-1.92%)
VolumeN/A
CapitalizationN/A
HBGHX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HBGHX vs. VGHCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBGHX is a Buy and VGHCX is a Buy.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 44.8B vs. HBGHX (121M). VGHCX pays higher dividends than HBGHX: VGHCX (0.79) vs HBGHX (0.24). HBGHX was incepted earlier than VGHCX: HBGHX (25 years) vs VGHCX (41 years). HBGHX is a more actively managed with annual turnover of: 28.00 vs. VGHCX (16.00). HBGHX has a lower initial minimum investment than VGHCX: HBGHX (0) vs VGHCX (3000). HBGHX annual gain was more profitable for investors over the last year : 3.98 vs. VGHCX (-5.50). VGHCX return over 5 years is better than : -3.33 vs. HBGHX (-33.15).
HBGHXVGHCXHBGHX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years41 years-
Gain YTD1.456-3.639-40%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets121M44.8B0%
Annual Yield % from dividends0.240.7931%
Returns for 1 year3.98-5.50-72%
Returns for 3 years-30.14-15.37196%
Returns for 5 years-33.15-3.33996%
Returns for 10 years-49.11-13.32369%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERB6.280.08
+1.29%
Verb Technology Company Inc
DNUT9.69-0.04
-0.41%
Krispy Kreme
TIPT21.21-0.24
-1.12%
Tiptree
APLT1.10-0.05
-4.35%
Applied Therapeutics
TECH71.41-3.86
-5.13%
Bio-Techne Corp